These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 29881239)

  • 1. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
    Jiang QQ; Han MF; Ma K; Chen G; Wan XY; Kilonzo SB; Wu WY; Wang YL; You J; Ning Q
    World J Gastroenterol; 2018 Jun; 24(21):2300-2310. PubMed ID: 29881239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis.
    Maiwall R; Kumar S; Chandel SS; Kumar G; Rastogi A; Bihari C; Sharma MK; Thakur B; Jamwal K; Nayak S; Mathur RP; Sarin SK
    Hepatol Int; 2015 Oct; 9(4):627-39. PubMed ID: 26329121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis.
    Huang Z; Lin C; Fang J; Wang N; Zhou R; Pan C
    Hepatol Int; 2015 Jul; 9(3):416-23. PubMed ID: 25980390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors and Outcomes of Acute Kidney Injury in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
    Yuan W; Zhang YY; Zhang ZG; Zou Y; Lu HZ; Qian ZP
    Am J Med Sci; 2017 May; 353(5):452-458. PubMed ID: 28502331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
    Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
    J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure.
    Jindal A; Bhadoria AS; Maiwall R; Sarin SK
    Liver Int; 2016 Jan; 36(1):59-67. PubMed ID: 26081914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of clinical features between patients with acute-on-chronic liver failure and decompensated liver cirrhosis combined with acute kidney injury].
    Kang WW; Duan LP; Xu MM; Kong M; Cao YY; Liu F; Han T; Duan ZP; Chen Y;
    Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):391-396. PubMed ID: 32536054
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial.
    Kandil MA; Abouelenain KM; Alsebaey A; Rashed HS; Afifi MH; Mahmoud MA; Yassen KA
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28564127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure.
    Shi X; Zhu P; Yan G; Liu C; Zhang C; Huang G; Zhang Y; Yan Z; Wang Y
    J Viral Hepat; 2016 Nov; 23(11):920-929. PubMed ID: 27397610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.
    Angeli P; Rodríguez E; Piano S; Ariza X; Morando F; Solà E; Romano A; García E; Pavesi M; Risso A; Gerbes A; Willars C; Bernardi M; Arroyo V; Ginès P;
    Gut; 2015 Oct; 64(10):1616-22. PubMed ID: 25311034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis.
    Zang H; Liu F; Liu H; You S; Zhu B; Wan Z; Xin S
    Hepatol Int; 2016 Sep; 10(5):807-18. PubMed ID: 27485174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
    Arora V; Maiwall R; Rajan V; Jindal A; Muralikrishna Shasthry S; Kumar G; Jain P; Sarin SK
    Hepatology; 2020 Feb; 71(2):600-610. PubMed ID: 30076614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?
    Davenport A; Sheikh MF; Lamb E; Agarwal B; Jalan R
    Kidney Int; 2017 Nov; 92(5):1058-1070. PubMed ID: 28844314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.
    Ariza X; Graupera I; Coll M; Solà E; Barreto R; García E; Moreira R; Elia C; Morales-Ruiz M; Llopis M; Huelin P; Solé C; Fabrellas N; Weiss E; Nevens F; Gerbes A; Trebicka J; Saliba F; Fondevila C; Hernández-Gea V; Fernández J; Bernardi M; Arroyo V; Jiménez W; Deulofeu C; Pavesi M; Angeli P; Jalan R; Moreau R; Sancho-Bru P; Ginès P;
    J Hepatol; 2016 Jul; 65(1):57-65. PubMed ID: 26988732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure.
    Huelin P; Piano S; Solà E; Stanco M; Solé C; Moreira R; Pose E; Fasolato S; Fabrellas N; de Prada G; Pilutti C; Graupera I; Ariza X; Romano A; Elia C; Cárdenas A; Fernández J; Angeli P; Ginès P
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):438-445.e5. PubMed ID: 27720915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.
    Ariza X; Solà E; Elia C; Barreto R; Moreira R; Morales-Ruiz M; Graupera I; Rodríguez E; Huelin P; Solé C; Fernández J; Jiménez W; Arroyo V; Ginès P
    PLoS One; 2015; 10(6):e0128145. PubMed ID: 26042740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
    Jaques DA; Spahr L; Berra G; Poffet V; Lescuyer P; Gerstel E; Garin N; Martin PY; Ponte B
    Nephrology (Carlton); 2019 Feb; 24(2):170-180. PubMed ID: 29369449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.
    Markwardt D; Holdt L; Steib C; Benesic A; Bendtsen F; Bernardi M; Moreau R; Teupser D; Wendon J; Nevens F; Trebicka J; Garcia E; Pavesi M; Arroyo V; Gerbes AL
    Hepatology; 2017 Oct; 66(4):1232-1241. PubMed ID: 28545169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
    Ma AT; Solé C; Juanola A; Escudé L; Napoleone L; Avitabile E; Pérez-Guasch M; Carol M; Pompili E; Gratacós-Ginés J; Soria A; Rubio AB; Cervera M; Moreta MJ; Morales-Ruiz M; Solà E; Poch E; Fabrellas N; Graupera I; Pose E; Ginès P
    J Hepatol; 2024 Sep; 81(3):441-450. PubMed ID: 38479614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study.
    Cao ZJ; Liu YH; Zhu CW; Yin S; Wang WJ; Tang WL; Zhao GD; Xu YM; Chen L; Zhou TH; Cai MH; Wang H; Cai W; Bao SS; Li H; Xie Q
    World J Gastroenterol; 2020 Feb; 26(6):645-656. PubMed ID: 32103873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.